Sign inCreate account

Report workspace tools

NCT02777320UNKNOWNanonymous

Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.

Sponsor

Source record

Pamukkale University

Phase

Source record

PHASE4

Modality

AI-normalized

small molecule

Target

AI-normalized

paracetamol, Ibuprofen

Indication / condition

AI-normalized

Sciatica

Intervention

Source record

paracetamol, Ibuprofen

Source & freshness

Source record

NCT ID

NCT02777320

Original source

ClinicalTrials.gov

Source last updated

Jul 15, 2016

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02777320

Title

Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.

Sponsor

Pamukkale University

Status

UNKNOWN

Phase

PHASE4

Condition raw

Sciatica

Condition normalized

Sciatica

Modality raw

small molecule

Modality normalized

small molecule

Target raw

paracetamol, Ibuprofen

Target normalized

paracetamol, Ibuprofen

Interventions

paracetamol, Ibuprofen

Public preview

Source record

Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments.

The objective of the study was to assess whether intravenous Paracetamol has superior Sciatica pain reduction will compare with Ibuprofen in emergency department (ED) adults.

Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02777320

Status

UNKNOWN

Phase

PHASE4

Sponsor

Pamukkale University

Executive brief

Investment-Ready Snapshot

Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments. The objective of the study was to assess whether intravenous Paracetamol has superior Sciatica pain reduction will compare with Ibuprofen in emergency department (ED) adults. Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJul 15, 2016
Internal syncJun 09, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02777320

Indication

Sciatica

Modality

small molecule

Target

paracetamol, Ibuprofen

Intervention

paracetamol, Ibuprofen

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.